umeclidinium (UMEC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for umeclidinium (UMEC), covering 2019-06-28 to 2019-06-28. Get the full timeline:
Most recent: Clinical Trial Update: A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI) [Phase 3]